Company Profile

Based in South San Francisco, Kezar Life Sciences is a clinical-stage biotechnology company committed to developing treatments for immune-mediated and oncologic disorders, hoping to help patients overcome their disease and live a better life. Kezar is pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, Kezar’s medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. KZR-616, a first-in-class selective immunoproteasome inhibitor, is being evaluated in severe autoimmune diseases. Additionally, KZR-261 is the first clinical candidate for the treatment of cancer from our protein secretion program and is undergoing IND-enabling activities for the program.

Latest Presentation

Industry Classifications



Pharmaceutical Preparation Manufacturing (325412)

Pharmaceutical Preparations (2834)

Contact Information

Investor Relations
Gitanjali Jain

Company Contact
Kezar Life Sciences, Inc.
4000 Shoreline Court
Suite 300
South San Francisco, CA 94080
T: (650) 822-5600